Online Pain Coping Skills Training for Joint Pain in Breast Cancer Survivors
Trial Summary
What is the purpose of this trial?
The main goal of this clinical trial is to test benefits of completing online pain coping skills training program in women who have been diagnosed with stage I-III breast cancer, who have completed their primary cancer treatment, who are taking an AI medication, and who have arthralgia. Arthralgia is a type of joint, bone, and muscle pain that is a common side effect of AI medications. The main questions it aims to answer are: 1. Whether online pain coping skills training reduces the severity of pain and the interference it causes in women's daily lives. 2. Whether online pain coping skills training improves emotional distress, quality of life, and adherence to AI medications. 3. Whether benefits of online pain coping skills training are at least partially caused by women's increased confidence that they can manage their pain and a reduction in unhelpful thinking patterns about pain. 4. Whether online pain coping skills training improves effects of AI medications on sleep problems and symptoms of menopause like hot flashes and night sweats. Participants can complete all parts of the study at home. They will: 1. Complete four sets of questionnaires throughout the study, which will take about 9 to 10 months. 2. Attend 3 meetings in the first month of the study, all of which can be held via a video conference. 3. Use an electronic pill bottle to track their use of their AI medication. 4. Be randomized (like flipping a coin) to one of two study arms: They will either receive education about AIs and arthralgia or they will receive this education along with access to an online pain coping skills training program. Research will compare the education group to the education plus online pain coping skills training group to see if online pain coping skills training has the benefits mentioned above.
Will I have to stop taking my current medications?
The trial does not require you to stop taking your current medications. However, if you are taking pain relievers, you need to be on a stable dose for at least 14 days before joining the study and should not plan to increase the dose during the study. You can discuss any changes with your doctor.
What data supports the effectiveness of this treatment for joint pain in breast cancer survivors?
Is online pain coping skills training safe for humans?
How is the Online Pain Coping Skills Training treatment different from other treatments for joint pain in breast cancer survivors?
Eligibility Criteria
This trial is for postmenopausal women over 18 with Stage I-III hormone receptor positive breast cancer, who've finished primary treatment and are on stable AI therapy experiencing joint pain. They must be English-speaking, able to use digital devices for online training, and likely to complete the study.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive education about AIs and arthralgia, with or without access to an online pain coping skills training program, completed over 8 to 10 weeks.
Follow-up 1
Participants' medication adherence is monitored using electronic pill bottles.
Follow-up 2
Participants are monitored for changes in menopause-specific quality of life.
Follow-up 3
Participants are monitored for changes in pain, emotional distress, sleep disturbance, and medication adherence.
Treatment Details
Interventions
- Education
- Online Pain Coping Skills Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
Northwestern University
Lead Sponsor
Duke University
Collaborator
National Cancer Institute (NCI)
Collaborator